Please login to the form below

Not currently logged in
Email:
Password:

Former Roche CEO and chairman joins Arix Bioscience

Dr Franz Humer becomes a senior independent director

Arix Bioscience Dr Franz HumerHealthcare and life science company Arix Bioscience has appointed Dr Franz Humer as a senior independent director.

Most recently, Dr Humer served as chairman and chief executive at Roche, having joined the company as head of pharmaceuticals in 1995 before becoming chief operating officer in 1996.

He is currently chairman of Diageo, a consumer goods company, and a non-executive director of Chugai Pharmaceuticals, Citigroup and Kite Pharma.

Jonathan Peacock, chairman of Arix Bioscience, said: “We are delighted to welcome to the board a director of Franz's stature.

“His experience and judgement will be a tremendous asset to Arix Bioscience as we continue to support emerging and innovative companies globally.

“Franz further strengthens a very experience board of executive and non-executive directors.”

10th November 2016

From: Sales

Share

Tags

Subscribe to our email news alerts

PMHub

Add my company
Research Partnership

Research Partnership, an Inizio Advisory Company, is a world-leading custom and syndicated global insights partner for health and life science...

Latest intelligence

The importance of accelerating clinical trial diversity
Diversity shouldn’t be an afterthought – it’s an investment in the credibility of scientific endeavour...
Digital Opinion Leaders: The Role of Influencers in Medical Communications
There are many informed, knowledgeable HCPs who talk about a disease state online, but not all of them are influencers. This paper explores who digital opinion leaders are and how...
Creating Hope Though Action – World Suicide Prevention Day
At Mednet Group, we believe that actions speak louder than words. That's why we're getting behind this year's Suicide Prevention Day campaign of 'creating hope through action'....